AUTHOREA
Log in Sign Up Browse Preprints

loading page

Which immunosuppressive drug is preferred in the treatment of toxic epidermal necrolysis during COVID-19 outbreak?
  • Saeedeh Farajzadeh,
  • Najmeh Ahramiyanpour
Saeedeh Farajzadeh
Kerman University of Medical Sciences

Corresponding Author:[email protected]

Author Profile
Najmeh Ahramiyanpour
Author Profile

Abstract

Toxic epidermal necrolysis (TEN) is a serious drug reaction. Its proper cure would be challenging during COVID-19 outbreak because of a dilemma regarding selecting the immunosuppressive drug. In this case presentation, we report a case of TEN who treat successfully with cyclosporine during COVID-19 outbreak in a referral COVID-19 hospital.

Peer review status:ACCEPTED

13 Feb 2021Submitted to Clinical Case Reports
Show details
Hide details
16 Feb 2021Submission Checks Completed
16 Feb 2021Assigned to Editor
23 Feb 2021Reviewer(s) Assigned
09 Apr 2021Review(s) Completed, Editorial Evaluation Pending
18 Apr 2021Editorial Decision: Accept